Anti-Tumor Activity of a Novel Compound-CDF Is Mediated by Regulating miR-21, miR-200, and PTEN in Pancreatic Cancer

• Bin Bao ,

  Contributed equally to this work with: Bin Bao, Shadan Ali

  Affiliation Department of Pathology, Wayne State University, Detroit, Michigan, United States of America

  ⨯
• Shadan Ali ,

  Contributed equally to this work with: Bin Bao, Shadan Ali

  Affiliation Division of Hematology/Oncology Karmanos Cancer Institute, Wayne State University, Detroit, Michigan, United States of America

  ⨯
• Dejuan Kong,

  Affiliation Department of Pathology, Wayne State University, Detroit, Michigan, United States of America

  ⨯
• Sanila H. Sarkar,

  Affiliation Department of Pathology, Wayne State University, Detroit, Michigan, United States of America

  ⨯
• Zhiwei Wang,

  Affiliation Department of Pathology, Wayne State University, Detroit, Michigan, United States of America

  ⨯
• Sanjeev Banerjee,

  Affiliation Department of Pathology, Wayne State University, Detroit, Michigan, United States of America

  ⨯
• Amro Aboukameel,

  Affiliation Division of Hematology/Oncology Karmanos Cancer Institute, Wayne State University, Detroit, Michigan, United States of America

  ⨯
• Subhash Padhye,

  Affiliation Dr. D. Y. Patil University, Pimpri, Pune, India

  ⨯
• Philip A. Philip,

  Affiliation Division of Hematology/Oncology Karmanos Cancer Institute, Wayne State University, Detroit, Michigan, United States of America

  ⨯
• Fazlul H. Sarkar

  * E-mail: fsarkar@med.wayne.edu

  Affiliation Department of Pathology, Wayne State University, Detroit, Michigan, United States of America

  ⨯